Clinical Trial Update: Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing acute effects of empagliflozin versus dapagliflozin on pulse wave velocity in adults with type 2 diabetes without complications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus Without Complications

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Diabetes Mellitus Type 2 Without Complication | Phase 3 | Status: UNKNOWN